Comparative Pharmacology
Head-to-head clinical analysis: BENTYL PRESERVATIVE FREE versus DICYCLOMINE HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BENTYL PRESERVATIVE FREE versus DICYCLOMINE HYDROCHLORIDE.
BENTYL PRESERVATIVE FREE vs DICYCLOMINE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dicyclomine is a muscarinic acetylcholine receptor antagonist (anticholinergic) that inhibits the action of acetylcholine on structures innervated by postganglionic parasympathetic nerves. It reduces smooth muscle spasm in the gastrointestinal tract by blocking M1, M2, and M3 receptors, with a predominant effect on M3 receptors in the gut.
Competitive antagonist of muscarinic acetylcholine receptors, inhibiting parasympathetic nerve impulses in the gastrointestinal tract, leading to smooth muscle relaxation.
20 mg orally three times daily; may increase to 40 mg three times daily if tolerated.
10-20 mg orally 3-4 times daily
None Documented
None Documented
Terminal elimination half-life: 1.9–3.3 hours (in healthy adults). Clinically, short half-life necessitates frequent dosing for sustained effect.
1.8 to 2.5 hours (terminal half-life, shorter in younger patients)
Renal: ~50% (mostly as metabolites), Biliary/Fecal: ~40% (as unchanged drug and metabolites), minor via enterohepatic circulation.
Renal (∼79.5% as unchanged drug and metabolites) with minor biliary/fecal elimination (∼8-10%)
Category C
Category A/B
Anticholinergic
Anticholinergic